<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04029558</url>
  </required_header>
  <id_info>
    <org_study_id>C024</org_study_id>
    <nct_id>NCT04029558</nct_id>
  </id_info>
  <brief_title>Effect of a Combination of Plant Extracts (BSL_EP024) on the Immune Response</brief_title>
  <official_title>Pilot Study of Nutritional Intervention, Randomized, Double Blind and Controlled Parallel Groups to Evaluate the Effect of the Consumption of the Combination of Plant Extracts (BSL_EP024) on the Immune Response in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biosearch S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biosearch S.A.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present trial is to study the effect of the combination of plant extracts
      (BSL_EP024) in the activation of the immune response.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      More than 90% of the diseases are related, directly or indirectly, with immune alterations.
      Traditionally, protection against infections and improvement of the immune response has been
      addressed by natural means through the use of plant extracts. This activity has been
      attributed to phenolic compounds.

      The aim of the present study is to evaluate the effect of the combination of plant extracts
      (BSL_EP024) on immunological response parameters.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 3, 2019</start_date>
  <completion_date type="Actual">July 3, 2019</completion_date>
  <primary_completion_date type="Actual">July 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IgM</measure>
    <time_frame>4 weeks</time_frame>
    <description>Immunoglobulin M plasma levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IgA</measure>
    <time_frame>4 weeks</time_frame>
    <description>Immunoglobulin A plasma levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IgG</measure>
    <time_frame>4 weeks</time_frame>
    <description>Immunoglobulin G plasma levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IL-2</measure>
    <time_frame>4 weeks</time_frame>
    <description>Plasma levels of interleukin-2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-8</measure>
    <time_frame>4 weeks</time_frame>
    <description>Plasma levels of interleukin-8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TNF-alpha</measure>
    <time_frame>4 weeks</time_frame>
    <description>Plasma levels of tumor necrosis factor alpha</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Immune Response</condition>
  <arm_group>
    <arm_group_label>Combination of plant extracts (BSL_EP024)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The volunteers will take two capsules daily with a combination of plant extracts (BSL_EP024)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The volunteers will take two capsules daily with maltodextrin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Combination of Plant Extracts (BSL_EP025)</intervention_name>
    <description>Each participant will consume 2 capsules daily at lunch for 8 weeks.</description>
    <arm_group_label>Combination of plant extracts (BSL_EP024)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Each participant will consume 2 capsules daily at lunch for 8 weeks.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adult between 18 and 55 years.

          -  Accept freely to participate in the study and sign the informed consent document.

        Exclusion Criteria:

          -  Be under pharmacological treatments that may affect the immune response
             (anti-inflammatory drugs of chronic or frequent use, antiallergic treatments).

          -  Have allergy to some plant extracts

          -  Suffer from gastric problems or ulcers.

          -  Receive treatment with anticoagulant activity.

          -  Have a low expectation of adherence to the study protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel Quesada, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical specialist in Endocrinology, Hospital San Cecilio de Granada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Biosearch Life</name>
      <address>
        <city>Granada</city>
        <state>Andalucia</state>
        <zip>18004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 22, 2019</study_first_submitted>
  <study_first_submitted_qc>July 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2019</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Immune response</keyword>
  <keyword>Plant extracts</keyword>
  <keyword>Dietary supplement</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

